Ft536

Other Medications

EU Experimental ES Not available 1 Clinical Trials

Description

FT536 is an experimental medicine being studied by Fate Therapeutics. It is currently in Phase 1 clinical trials for advanced solid tumors, including colorectal cancer. These early-stage trials are designed to determine the safest dose and how patients respond to the treatment. FT536 is being tested both on its own (monotherapy) and in combination with certain monoclonal antibodies (a type of targeted therapy). The trials are looking at patients with different types of advanced solid tumors, including colorectal cancer, to see if FT536 is effective and safe. The specific way FT536 works is still being investigated in these trials.

Mechanism of Action

FT536 is being studied as a potential treatment for advanced solid tumors. It is being investigated in Phase 1 trials, both alone and in combination with monoclonal antibodies. The specific molecular target or mechanism of action for FT536 is currently being characterized in clinical trials.

Side Effects

Because FT536 is an experimental drug in early-phase clinical trials (Phase 1) The full range of potential side effects is still being evaluated. Information about side effects from these trials is not yet widely available. As more data becomes available from ongoing studies A clearer picture of the side effect profile will emerge.

Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.

Clinical Trials

NCT05395052 Phase 1
Archived
FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid Tumors
United States

Quick Info

CategoryOther Medications
EU EMA StatusExperimental
ES Spain AccessNot available
Clinical Trials1
View Clinical Trials Back to Drug Glossary

Related Medications

Uracil
Other Medications
768 trials
Leucovorin
Other Medications
627 trials
Trifluridine
Other Medications
45 trials
Paclitaxel
Other Medications
43 trials
Cyclophosphamid
Other Medications
40 trials
Cyclophosphamide
Other Medications
39 trials

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.